Areteia Therapeutics appoints Ian Read as Chairman of its Board of Directors
– USA, NC – Areteia Therapeutics, Inc. today announced the appointment of Ian Read as Chairman of its Board of Directors, following the launch of the Company by Knopp Biosciences and Population Health Partners and the successful completion of a $350 million Series A financing led by Bain Capital Life Sciences, with participation from Access Biotechnology, GV, ARCH Venture Partners, Saturn Partners, Sanofi, Maverick Capital, and Population Health Partners.…
